跳至主要内容
临床试验/NCT02129738
NCT02129738已完成不适用

Is Reuse of Intermittent Urethral Catheters Safe and Preferred? A Prospective, Observational Study Evaluating Reuse of Catheters and Switch to Single-use.

Wellspect HealthCare7 个研究点 分布在 2 个国家目标入组 39 人开始时间: 2014年6月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
7
主要终点
Proportion of catheters with bacterial contamination (Y/N)

研究概览

简要总结

The purpose of this study is to investigate and document real life safety and satisfaction of re-use of urethral catheters for intermittent self catheterization. The study will collect re-used catheters from included patients and compare those to a control group with regard to bacterial contamination and mechanical properties. A four week prospective evaluation will follow where the patients will be given catheters intended for single-use.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Provision of informed consent
  • •Female and/or male aged 18 years and over
  • •Intermittent self-catheterization as primary bladder management method, defined as a normal catheterization frequency of at least 4 times daily
  • •Reuse of the same silicon, rubber (latex) or plastic (e.g. vinyl, PVC) catheter
  • •Accustomed intermittent catheterization user, defined as intermittent catheterization use for at least 3 months
  • •Able to use catheters of size:
  • •40 cm, CH12 or CH14; 16'', FR12 or FR14; 15 cm, CH10 or CH12; 6'', FR10 or FR12;

排除标准

  • •Antibiotic treatment within 4 weeks prior study inclusion
  • •Drug or alcohol abuse or other disease of addiction
  • •Immunocompromising diseases or medications
  • •Known urological/renal anatomical abnormalities with potential impact on subject´s compliance as judged by the investigator
  • •Diagnosis of severe fecal incontinence that may compromise study participation as judged by the investigator
  • •Involvement in the planning and conduct of the study (applies to both Wellspect HealthCare staff and staff at the study site)
  • •Previous enrollment in the present study
  • •Simultaneous participation in another clinical study that may interfere with the present study, as judged by the investigator
  • •Severe non-compliance to protocol as judged by the investigator and/or Wellspect HealthCare

研究组 & 干预措施

LoFric

Experimental

LoFric catheters

干预措施: LoFric catheters (Device)

结局指标

主要结局

Proportion of catheters with bacterial contamination (Y/N)

时间窗: At Baseline (Visit 1)

Proportion of catheters with bacterial contamination verified by culturing/incubation and visual inspection by Scanning Electron Microscope (SEM).

次要结局

  • Bacterial quantification by incubation.(At Baseline (Visit 1))
  • Pathogen identification by incubation.(At Baseline (Visit 1))
  • Material properties and bacteria/particle/tissue visualization by SEM.(At Baseline (Visit 1))
  • Presence of reuse found in medical records, patient reported questionnaires and patient interviews.(At Baseline (Visit 1) and at 4 weeks (Visit 2))
  • Bacterial level in urine sample(At Baseline and 4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验